In total, close to 300,000 patients were included
Medina PJ, Sipols JM, George JN (2001) Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
This can occur through mechanisms such as slowing carbohydrate absorption, improving insulin sensitivity, interacting with other satiety hormones or via the microbiome
Gunne, S
The population who switched were made up of a higher percentage of people in the 45-64 age range, female, white, not Hispanic or Latino, those with overweight/obesity, T2D, and those who initiated treatment before 2021
GLP-1 drugs for weight loss According to the U.S